Cargando…

Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c

SIMPLE SUMMARY: Targeted therapy directed against many biomarkers has not shown significant improvement in outcome in TNBC, and therefore it is urgent to discover more biomarker candidates. Here, we found a DNA aptamer that bound to TNBC cells and identified CD49c as a specific surface marker for TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Quanyuan, Zeng, Zihua, Qi, Jianjun, Zhao, Yingxin, Liu, Xiaohui, Chen, Zhenghu, Zhou, Haijun, Zu, Youli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946172/ https://www.ncbi.nlm.nih.gov/pubmed/35326720 http://dx.doi.org/10.3390/cancers14061570

Ejemplares similares

Aptamer Cocktail to Detect Multiple Species of Mycoplasma in Cell Culture
por: Wan, Quanyuan, et al.
Publicado: (2020)

Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
por: Qi, Jianjun, et al.
Publicado: (2022)

Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy
por: Zeng, Zihua, et al.
Publicado: (2021)

Oligonucleotide aptamers for pathogen detection and infectious disease control
por: Wan, Quanyuan, et al.
Publicado: (2021)

Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
por: Zeng, Zihua, et al.
Publicado: (2020)

A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
por: Zeng, Zihua, et al.
Publicado: (2014)

Biostable ssDNA Aptamers Specific for Hodgkin Lymphoma
por: Parekh, Parag, et al.
Publicado: (2013)

Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
por: Zeng, Zihua, et al.
Publicado: (2014)

Aptamer technology: a new approach to treat lymphoma?
por: Zu, Youli
Publicado: (2020)

A Highlight of Recent Advances in Aptamer Technology and Its Application
por: Sun, Hongguang, et al.
Publicado: (2015)

Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells
por: Velázquez-Quesada, Inés, et al.
Publicado: (2020)

Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer
por: Pleiko, Karlis, et al.
Publicado: (2023)

Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy
por: Li, Huan, et al.
Publicado: (2017)

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
por: Gómez-Miragaya, Jorge, et al.
Publicado: (2017)

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
por: Sun, Hongguang, et al.
Publicado: (2014)

Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
por: Yang, Shuanghui, et al.
Publicado: (2018)

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
por: Camorani, Simona, et al.
Publicado: (2020)

Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer
por: Camorani, Simona, et al.
Publicado: (2020)

ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
por: Yu, Ge, et al.
Publicado: (2016)

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
por: Camorani, Simona, et al.
Publicado: (2018)

Selection of aptamers against triple negative breast cancer cells using high throughput sequencing
por: Ferreira, Débora, et al.
Publicado: (2021)

Interleukin-2 Functions in Anaplastic Large Cell Lymphoma Cells through Augmentation of Extracellular Signal-Regulated Kinases 1/2 Activation
por: Ito, Masanori, et al.
Publicado: (2011)

Benzo[f]indole-4,9-dione Derivatives Effectively Inhibit the Growth of Triple-Negative Breast Cancer
por: Guerra, Fabiana Sélos, et al.
Publicado: (2021)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX
por: Haghighi, Mansoureh, et al.
Publicado: (2018)

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
por: Agnello, Lisa, et al.
Publicado: (2021)

Support Vector Machine Classification of Streptavidin-Binding Aptamers
por: Yu, Xinliang, et al.
Publicado: (2014)

Binding Interactions of Peptide Aptamers
por: New, Roger R. C., et al.
Publicado: (2020)

Weak Binding of Levamisole by the Cocaine-Binding Aptamer Does Not Interfere with an Aptamer-Based Detection Assay
por: Shoara, Aron A., et al.
Publicado: (2021)

Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
por: Ma, Qi, et al.
Publicado: (2019)

Ink4a/Arf(−/−) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(−) quiescent cells
por: Kai, Kazuharu, et al.
Publicado: (2013)

In Silico Approaches for the Identification of Aptamer Binding Interactions to Leptospira spp. Cell Surface Proteins
por: Almazar, Chembie A., et al.
Publicado: (2023)

Targeting triple‐negative breast cancer with an aptamer‐functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies
por: Chou, Yi-Te, et al.
Publicado: (2021)

Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer
por: Zhou, Shu-Min, et al.
Publicado: (2015)

S143: NATURAL CLONAL EVOLUTION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH BIMODAL CD49D EXPRESSION REVEALS CD49D PLASTICITY
por: Tissino, Erika, et al.
Publicado: (2023)

Conformational dynamics of the tetracycline-binding aptamer
por: Förster, Ute, et al.
Publicado: (2012)

DNA-Aptamers Binding Aminoglycoside Antibiotics
por: Nikolaus, Nadia, et al.
Publicado: (2014)

Methods for Improving Aptamer Binding Affinity
por: Hasegawa, Hijiri, et al.
Publicado: (2016)

Idiosyncrasies of thermofluorimetric aptamer binding assays
por: Damase, Tulsi Ram, et al.
Publicado: (2019)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q570oot7r8aldq7ktlam75ddf1